第一工業製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 化学 | 4461/E00885 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2023/07/28 | 日証協 | 94,391株 | +18.6% | 104,206株 | +32.49% | 144,165株 | +13.1% | 21,926株 | -21.46% |
2023/07/21 | 日証協 | 79,591株 | +24.57% | 78,650株 | +532.95% | 127,471株 | +14.46% | 27,917株 | +70.41% |
2023/07/14 | 日証協 | 63,891株 | -28.94% | 12,426株 | -94% | 111,363株 | -19.46% | 16,382株 | +8.81% |
2023/07/07 | 日証協 | 89,913株 | +5.56% | 206,989株 | -36.88% | 138,279株 | +4.66% | 15,055株 | -48.11% |
2023/06/30 | 日証協 | 85,179株 | +3.5% | 327,939株 | +157.07% | 132,122株 | +6.2% | 29,014株 | -1.3% |
2023/06/23 | 日証協 | 82,296株 | -6.59% | 127,570株 | -56.55% | 124,405株 | +6.85% | 29,397株 | +89.32% |
2023/06/16 | 日証協 | 88,102株 | -0.79% | 293,599株 | +9.48% | 116,425株 | +2.47% | 15,528株 | +27.28% |
2023/06/09 | 日証協 | 88,802株 | +3.26% | 268,184株 | +33.42% | 113,614株 | +2.25% | 12,200株 | -43.26% |
2023/06/02 | 日証協 | 86,002株 | +14.27% | 201,012株 | +2.93% | 111,110株 | +12.76% | 21,503株 | +61.29% |
2023/05/26 | 日証協 | 75,259株 | +3.6% | 195,285株 | +131.26% | 98,535株 | +4.33% | 13,332株 | +1.66% |
2023/05/19 | 日証協 | 72,646株 | +25.37% | 84,443株 | +41.23% | 94,450株 | +3.75% | 13,114株 | +465.75% |
2023/05/12 | 日証協 | 57,946株 | -1.28% | 59,791株 | +1738.03% | 91,040株 | -0.65% | 2,318株 | -29.78% |
2023/05/02 | 日証協 | 58,699株 | -9.2% | 3,253株 | +91.92% | 91,639株 | -2.02% | 3,301株 | +2.48% |
2023/04/28 | 日証協 | 64,646株 | -11.5% | 1,695株 | -98.84% | 93,528株 | -15.74% | 3,221株 | -67.13% |
2023/04/21 | 日証協 | 73,046株 | +16.42% | 146,256株 | -9.81% | 110,999株 | +6.5% | 9,799株 | -55.25% |
2023/04/14 | 日証協 | 62,746株 | +81.11% | 162,173株 | +94.67% | 104,220株 | +13.2% | 21,899株 | +149.48% |
2023/04/07 | 日証協 | 34,646株 | -3.09% | 83,305株 | +64.03% | 92,069株 | +44.71% | 8,778株 | -83.16% |
2023/03/31 | 日証協 | 35,749株 | -38.91% | 50,786株 | -27.74% | 63,622株 | -42.13% | 52,120株 | +18.91% |
2023/03/24 | 日証協 | 58,521株 | +42.74% | 70,280株 | +105.89% | 109,949株 | +26.55% | 43,831株 | +102.23% |
※株式分割は考慮していませんのでご注意ください。
Page Top